Share：
Share this content in WeChat
X
[Chinese][PDF]361
• Review •
Advances of medical imaging in Moyamoya disease
CHEN Jialu  OUYANG Feng  WU Qin  ZENG Xianjun 

Cite this article as: CHEN J L, OUYANG F, WU Q, et al. Advances of medical imaging in Moyamoya disease[J]. Chin J Magn Reson Imaging, 2025, 16(5): 190-197. DOI:10.12015/issn.1674-8034.2025.05.029.


[Abstract] Moyamoya disease is a rare and progressive cerebrovascular disorder characterized by intracranial arterial stenosis or occlusion, accompanied by the formation of abnormal vascular networks at the base of the brain. Most patients exhibit poor prognosis and are prone to ischemic or hemorrhagic stroke. The main treatment method is revascularization surgery, and delayed diagnosis or improper treatment may lead to irreparable consequences. In recent years, imaging examinations have played a pivotal role in the diagnosis, classification, disease assessment, and therapeutic monitoring of Moyamoya disease. However, existing review articles have failed to comprehensively summarize the imaging techniques for Moyamoya disease and lack updates on recent advancements in relevant diagnostic technologies. This review focuses on the current imaging modalities and their clinical applications in Moyamoya disease, as well as specific imaging biomarkers for stroke risk and prognostic prediction. The aim is to provide radiologists and clinicians with a comprehensive reference for imaging-based diagnosis and treatment decision-making, while offering insights for optimizing personalized precision medicine strategies for Moyamoya disease.
[Keywords] Moyamoya disease；medical imaging；advance；magnetic resonance imaging；vascular imaging；artificial intelligence

CHEN Jialu   OUYANG Feng   WU Qin   ZENG Xianjun*  

Department of Imaging, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China

Corresponding author: ZENG X J, E-mail: Xianjun-zeng@126.com

Conflicts of interest   None.

Received  2025-01-25
Accepted  2025-05-10
DOI: 10.12015/issn.1674-8034.2025.05.029
Cite this article as: CHEN J L, OUYANG F, WU Q, et al. Advances of medical imaging in Moyamoya disease[J]. Chin J Magn Reson Imaging, 2025, 16(5): 190-197. DOI:10.12015/issn.1674-8034.2025.05.029.

[1]
Neurosurgical Branch of Chinese Medical Association. Chinese Expert Consensus on the Diagnosis and Treatment of Moyamoya Disease and Moyamoya Syndrome (2024 Edition)[J]. Chinese Journal of Neurosurgery, 2024, 40(3): 220-229. DOI: 10.3760/cma.j.cn112050-20231119-00177.
[2]
ZHANG D, HUANG L, HUANG Z, et al. Epidemiology of Moyamoya disease in China: A nationwide hospital-based study[J/OL]. Lancet Reg Health West Pac, 2021, 18: 100331 [2025-01-25]. https://doi.org/10.1016/j.lanwpc.2021.100331. DOI: 10.1016/j.lanwpc.2021.100331.
[3]
DORSCHEL K B, WANEBO J E. Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases[J]. Appl Clin Genet, 2021, 14: 145-171. DOI: 10.2147/TACG.S252736.
[4]
HE S, ZHOU Z, CHENG M Y, et al. Advances in Moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions[J/OL]. MedComm, 2025, 6(2): e70054 [2025-01-25]. https://doi.org/10.1002/mco2.7005. DOI: 10.1002/mco2.7005.
[5]
ZHAO Q S, WANG G, XIAO H J, et al. Characteristics of collateral circulation in adult Moyamoya disease based on modified Suzuki staging and its clinical significance[J]. Journal of Southern Medical University, 2018, 38(4): 483-489. DOI: 10.3969/j.issn.1673-4254.2018.04.19.
[6]
TEO M, FURTADO S, KANEKO O F, et al. Validation and Application for the Berlin Grading System of Moyamoya Disease in Adult Patients[J]. Neurosurgery, 2020, 86(2): 203-212. DOI: 10.1093/neuros/nyz025.
[7]
LIU Z W, HAN C, ZHAO F, et al. Collateral Circulation in Moyamoya Disease: A New Grading System[J]. Stroke, 2019, 50(10): 2708-2715. DOI: 10.1161/STROKEAHA.119.024487.
[8]
WU H Z, WANG Y, WANG Q R, et al. Head and neck CT angiography has higher diagnostic and value for intracranial aneurysms[J]. Journal of Molecular Imaging, 2023, 46(2): 271-275. DOI: 10.12122/j.issn.1674-4500.2023.02.15.
[9]
YIN L, GENG C J, ZHANG Y J, et al. The value of 320-slice CT in follow-up of spontaneous subarachnoid hemorrhage patients with negative DSA angiography[J]. Journal of Clinical Radiology, 2021, 40(5): 879-883. DOI: 10.13437/j.cnki.jcr.2021.05.010.
[10]
LU Y, CAO R Y, YAN J, et al. One-stop CT evaluation of the relationship between ivy sign and cerebral hemodynamics and collateral circulation in patients with Moyamoya disease and Moyamoya syndrome[J]. Chinese Medical Imaging Technology, 2022, 38(12): 1780-1785. DOI: 10.13929/j.issn.1003-3289.2022.12.005.
[11]
WU X K, XIAO K, Yang J L. Comparison of the assessment value of MRI angiography and DSA in vascular grading of Moyamoya disease patients[J]. Modern Medical Imaging, 2024, 33(8): 1387-1390. DOI: 10.3969/j.issn.1006-7035.2024.08.001.
[12]
IBRAHIM A Y, AMRIABADI A, SHROFF M M, et al. Fractional Flow on TOF-MRA as a Measure of Stroke Risk in Children with Intracranial Arterial Stenosis[J]. AJNR Am J Neuroradiol, 2020, 41(3): 535-541. DOI: 10.3174/ajnr.A6441.
[13]
UCHINO H, ITO M, FUJIMA N, et al. Predictive value of the hemispheric magnetic resonance angiography score on the development of indirect pial synangiosis after combined revascularization surgery for adult Moyamoya disease[J/OL]. Acta Neurochir (Wien), 2024, 166(1): 181 [2025-01-25]. https://doi.org/10.1007/s00701-024-06079-x. DOI: 10.1007/s00701-024-06079-x.
[14]
CALLONI S F, PERROTA M, ROVERI L, et al. The role of CE-MRA of the supraortic vessels in the detection of associated intracranial pathology[J]. Neurol Sci, 2021, 42(12): 5131-5137. DOI: 10.1007/s10072-021-05222-1.
[15]
SUZUKI T, HASEGAWA H, FUJIWARA H, et al. Visualization of cortical neoangiogenesis after combined revascularization surgery in Moyamoya disease using silent MRA[J]. Neuroradiology, 2025, 67(2): 321-329. DOI: 10.1007/s00234-024-03486-w.
[16]
SOLLMANN N, LIEBL H, PREIBISCH C, et al. Super-selective ASL and 4D ASL-based MR Angiography in a Patient with Moyamoya Disease: Case Report[J]. Clin Neuroradiol, 2021, 31(2): 515-519. DOI: 10.1007/s00062-020-00961-8.
[17]
SUI B, SANNANANJA B, ZHU C, et al. Report from the society of magnetic resonance angiography: clinical applications of 7T neurovascular MR in the assessment of intracranial vascular disease[J]. J Neurointerv Surg [J]. 2024, 16(8): 846-851. DOI: 10.1136/jnis-2023-020668.
[18]
KONG L J, HUI P J, DING Y F, et al. Ultrasonic hemodynamic study of intracranial and extracranial vessels in Moyamoya disease[J]. Chinese Journal of Ultrasound in Medicine, 2021, 37(11): 1201-1204. DOI: 10.3969/j.issn.1002-0101.2021.11.001.
[19]
PAN H, SHI W, LI H, et al. Clinical Prediction of Surgical Revascularization Outcome in Moyamoya Disease Via Transcranial Color Sonography[J/OL]. J Stroke Cerebrovasc Dis, 2020, 29(11): 105154 [2025-01-25]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105154. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105154.
[20]
HUA Y, ZHONG J X, JIA L Y, et al. Chinese Expert Consensus on Several Issues of Cerebral Vascular Ultrasound Detection[J]. Chinese Journal of Cerebrovascular Diseases, 2024, 21(11): 782-793. DOI: 10.3969/j.issn.1672-5921.2024.11.009.
[21]
HUANG X L, WU B X, LIU A Y, et al. High-resolution magnetic resonance vessel wall imaging in ischemic stroke and carotid artery atherosclerotic stenosis: A review[J/OL]. Heliyon, 2024, 10(7): e27948 [2025-01-25]. https://doi.org/10.1016/j.heliyon.2024.e27948. DOI: 10.1016/j.heliyon.2024.e27948.
[22]
SHE D J, WU Y Q, ZHANG Y Y, et al. Study on the relationship between high-resolution MRI three-dimensional variable flip angle fast spin echo imaging technique and the characteristics of middle cerebral artery plaques and cerebral infarction[J]. Journal of Clinical Radiology, 2020, 39(5): 870-874. DOI: 10.13437/j.cnki.jcr.2020.05.006.
[23]
YADAV K L, GUPTA A, SWARNKAR C P, et al. Role of Vessel Wall Magnetic Resonance Imaging in the Diagnosis of Intracranial Vasculopathies[J/OL]. Cureus, 2024, 16(11): e73714 [2025-01-25]. https://doi.org/10.7759/cureus.73714. DOI: 10.7759/cureus.73714.
[24]
CHONG Z, ZHANG S, YUE X, et al. Nomogram Based on High-Resolution Vessel Wall MRI Features to Differentiate Moyamoya Disease From Atherosclerosis-Associated Moyamoya Vasculopathy[J]. J Magn Reson Imaging, 2025, 61(1): 394-403. DOI: 10.1002/jmri.29407.
[25]
HAO F, HAN C, LU M, et al. High-resolution MRI vessel wall enhancement in Moyamoya disease: risk factors and clinical outcomes.[J]. Eur Radiol, 2024, 34(8): 5179-5189. DOI: 10.1007/s00330-023-10535-0.
[26]
ZHAO M Y, FAN A P, CHEN D Y, et al. Using arterial spin labeling to measure cerebrovascular reactivity in Moyamoya disease: Insights from simultaneous PET/MRI[J]. J Cereb Blood Flow Metab, 2022, 42(8): 1493-1506. DOI: 10.1177/0271678X221083471.
[27]
WANG J B, WANG J J, ZHANG C J, et al. Application value of high-resolution MRI and CT perfusion imaging quantitative parameters in Moyamoya disease patients[J]. Hebei Medical Journal, 2024, 46(10): 1516-1519. DOI: 10.3969/j.issn.1002-7386.2024.10.016.
[28]
HAN Q, YAO F, ZHANG Z, et al. Evaluation of Revascularization in Different Suzuki Stages of Ischemic Moyamoya Disease by Whole-Brain CT Perfusion[J/OL]. Front Neurol, 2021, 12: 683224 [2025-01-25]. https://doi.org/10.3389/fneur.2021.683224. DOI: 10.3389/fneur.2021.683224.
[29]
LI S M, CHENG J L, WANG K Y. Evaluation of cerebral hemodynamics in Moyamoya disease patients with different clinical symptoms by magnetic resonance perfusion imaging[J]. Journal of Clinical Radiology, 2018, 37(12): 1981-1984. DOI: 10.13437/j.cnki.jcr.2018.12.008.
[30]
ZHANG J, XIA C, LIU Y, et al. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease[J/OL]. Medicine (Baltimore), 2018, 97(41): e12768 [2025-01-25]. https://doi.org/10.1097/MD.0000000000012768. DOI: 10.1097/MD.0000000000012768.
[31]
SETTA K, MATSUDA T, SASAKI M, et al. Diagnostic Accuracy of Screening Arterial Spin-Labeling MRI Using Hadamard Encoding for the Detection of Reduced CBF in Adult Patients with Ischemic Moyamoya Disease[J]. AJNR Am J Neuroradiol, 2021, 42(8): 1403-1409. DOI: 10.3174/ajnr.A7167.
[32]
YUAN J, QU J, LV Z, et al. Assessment of blood supply of the external carotid artery in Moyamoya disease using super-selective pseudo-continuous arterial spin labeling technique.[J]. Eur Radiol, 2021, 31(12): 9287-9295. DOI: 10.1007/s00330-021-07893-y.
[33]
LI J, MENG Q, HUANG L, et al. Pseudo-continuous and territorial arterial spin labeling MRI for assessment of cerebral perfusion in Moyamoya disease after revascularization: A comparative study with digital subtraction angiography[J/OL]. Heliyon, 2024, 10(17): e37368 [2025-01-25]. https://doi.org/10.1016/j.heliyon.2024.e37368. DOI: 10.1016/j.heliyon.2024.e37368.
[34]
GAO F, ZHAO W, ZHENG Y, et al. Intravoxel Incoherent Motion Magnetic Resonance Imaging Used in Preoperative Screening of High-Risk Patients With Moyamoya Disease Who May Develop Postoperative Cerebral Hyperperfusion Syndrome[J/OL]. Front Neurosci, 2022, 16: 826021 [2025-01-25]. https://doi.org/10.3389/fnins.2022.826021. DOI: 10.3389/fnins.2022.826021.
[35]
UCHINO H, KAZUMATA K, ITO M, et al. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for Moyamoya disease[J]. Neurosurg Rev, 2021, 44(1): 599-605. DOI: 10.1007/s10143-020-01265-8.
[36]
LEI Y, SONG B, CHEN L, SU J, et al. Reconfigured functional network dynamics in adult Moyamoya disease: a resting-state fMRI study[J]. Brain Imaging Behav, 2020, 14(3): 715-727. DOI: 10.1007/s11682-018-0009-8.
[37]
ZERWECK L, RODER C, HAUSER T K, et al. Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET[J]. Neuroradiology, 2022, 64(3): 553-563. DOI: 10.1007/s00234-021-02814-8.
[38]
LI C Q, GE Q M, SHU H Y, et al. Investigation of Altered Spontaneous Brain Activities in Patients With Moyamoya Disease Using Percent Amplitude of Fluctuation Method: A Resting-State Functional MRI Study[J/OL]. Front Neurol, 2021, 12: 801029 [2025-01-25]. https://doi.org/10.3389/fneur.2021.801029. DOI: 10.3389/fneur.2021.801029.
[39]
WANG Y Y, LI J, LIN F, et al. Network centrality alterations in patients with Moyamoya disease after combined revascularization surgery: a resting-state fMRI study[J/OL]. Neuroreport, 2025 [2025-01-25]. https://pubmed.ncbi.nlm.nih.gov/40269594/. DOI: 10.1097/WNR.0000000000002154.
[40]
LIU Z, HE S, XU Z, et al. Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease[J/OL]. BMC Neurol, 2020, 20(1): 302 [2025-01-25]. https://doi.org/10.1186/s12883-020-01876-0. DOI: 10.1186/s12883-020-01876-0.
[41]
HARA S, HORI M, HAGIWARA A, et al. Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease[J]. AJNR Am J Neuroradiol, 2020, 41(9): 1618-1624. DOI: 10.3174/ajnr.A6708.
[42]
SU J, NI W, YANG B, et al. Preliminary Study on the Application of Ultrahigh Field Magnetic Resonance in Moyamoya Disease[J/OL]. Oxid Med Cell Longev, 2021, 2021: 5653948 [2025-01-25]. https://doi.org/10.1155/2021/5653948. DOI: 10.1155/2021/5653948.
[43]
KISHI S, MAEDA M, KOGUE R, et al. SWI brush sign of cerebral parenchymal veins in central nervous system diseases[J]. Jpn J Radiol, 2024, 43(5): 726-735. DOI: 10.1007/s11604-024-01723-z.
[44]
KISHI S, MAEDA M, TANAKA F, et al. Cortical Brush Sign: A Novel Finding on Thin-slice 3T Susceptibility-weighted Imaging in Acute Cerebral Infarct and Cerebral Venous Thrombosis[J]. Magn Reson Med Sci, 2024, 23(2): 238-241. DOI: 10.2463/mrms.bc.2022-0120.
[45]
QIAN W Q, TIKUN S, QIU Q Q, et al. Asymmetric Cortical Vessel Sign Indicates Hemodynamic Deficits in Adult Patients with Moyamoya Disease[J/OL]. World Neurosurg, 2019, 127: e137-e141 [2025-01-25]. https://pubmed.ncbi.nlm.nih.gov/30862600/. DOI: 10.1016/j.wneu.2019.02.187.
[46]
LIU N L, WANG Y H, ZHU Y S, et al. Application of Compressed Sensing Technology in Time-of-Flight Magnetic Resonance Angiography of the Head[J]. Modern Medicine, 2024, 52(10): 1552-1556. DOI: 10.3969/j.issn.1671-7562.2024.10.010.
[47]
LI Q, SU C Q, WU P F, et al. Clinical value of high-resolution compressed sensing TOF-MRA in Moyamoya disease staging and bleeding-related vascular assessment[J]. Chin J Magn Reson Imaging, 2023, 14(4): 29-33. DOI: 10.12015/issn.1674-8034.2023.04.006.
[48]
LI Y, LI W, XIA C, et al. Ivy Sign: Usefulness in Diagnosis and Prognosis Prediction of Moyamoya Disease[J/OL]. World Neurosurg, 2024, 181: e1012-e1018 [2025-01-25]. https://doi.org/10.1016/j.wneu.2023.11.029. DOI: 10.1016/j.wneu.2023.11.029.
[49]
LEE S H, CHO W S, LEE H C, et al.. The ivy sign as a radiological marker for follow-up of postoperative cerebral perfusion status in adult Moyamoya disease[J]. J Neurosurg, 2023, 139(6): 1697-1704. DOI: 10.3171/2023.4.JNS23294.
[50]
WANG J, ZHANG Q, DI F, et al. Angiographic features and progression risk factors in children with asymptomatic Moyamoya disease[J/OL]. Front Neurol, 2024, 15: 1484132 [2025-01-25]. https://doi.org/10.3389/fneur.2024.1484132. DOI: 10.3389/fneur.2024.1484132.
[51]
SUN J, SHI Z, YU L, et al. Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research[J/OL]. BMC Neurol, 2022, 22(1): 12 [2025-01-25]. https://doi.org/10.1186/s12883-021-02511-2. DOI: 10.1186/s12883-021-02511-2.
[52]
YU J, DU Q, XIE H, et al. What and why: the current situation and future prospects of "ivy sign" in Moyamoya disease[J/OL]. Ther Adv Chronic Dis, 2020, 11: 2040622320960004 [2025-01-25]. https://doi.org/10.1177/2040622320960004. DOI: 10.1177/2040622320960004.
[53]
PARK J I, HONG J S, RYU J, et al. Identification of Sulcal Hyperintense Vessel (Vessel Wall MR Ivy Sign) in Adult Moyamoya Disease with High-resolution Vessel Wall Imaging: A Pilot Study[J/OL]. J Korean Neurosurg Soc, 2025 [2025-01-25]. https://pubmed.ncbi.nlm.nih.gov/39788750/. DOI: 10.3340/jkns.2024.0096.
[54]
UKAI R, MIKAMII T, NAGAHAMA H, et al. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease[J/OL]. J Stroke Cerebrovasc Dis, 2020, 29(9): 105058 [2025-01-25]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105058. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105058.
[55]
PEER S, SINGH P. Intraluminal arterial transit artifact as a predictor of intracranial large artery stenosis on 3D time of flight MR angiography: Expanding the application of arterial spin labeling MRI in ischemic stroke[J/OL]. J Clin Imaging Sci, 2023, 13: 17 [2025-01-25]. https://doi.org/10.25259/JCIS_27_2023. DOI: 10.25259/JCIS_27_2023.
[56]
KURODA S, YAMAMOTO S, FUNAKI T, et al. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE)[J]. Stroke, 2023, 54(6): 1494-1504. DOI: 10.1161/STROKEAHA.122.041932.
[57]
HAO X, ZHANG C, YANG C, et al. Introducing an index on prediction of post-revascularization cerebral infarction using preoperative CT perfusion parameters in Moyamoya disease[J/OL]. Insights into imaging, 2025, 16(1): 2 [2025-01-25]. https://doi.org/10.1186/s13244-024-01882-7. DOI: 10.1186/s13244-024-01882-7.
[58]
SHI Z, MA G, ZHANG D. Haemodynamic analysis of adult patients with Moyamoya disease: CT perfusion and DSA gradings[J]. Stroke Vasc Neurol, 2021, 6(1): 41-47. DOI: 10.1136/svn-2019-000317.
[59]
XIE A, WANG L, SONG P, et al. Predictive value of CT perfusion-derived parameters in Moyamoya disease[J/OL]. Clin Neurol Neurosurg, 2023, 232: 107869 [2025-01-25]. https://doi.org/10.1016/j.clineuro.2023.107869. DOI: 10.1016/j.clineuro.2023.107869.
[60]
TORTORA D, SCAVETTA C, REBELLA G, et al. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric Moyamoya vasculopathy[J]. Neuroradiology, 2020, 62(8): 1003-1015. DOI: 10.1007/s00234-020-02446-4.
[61]
GUO X, YUAN X, GAO L, et al. Encephaloduroarteriosynangiosis (EDAS) treatment of Moyamoya syndrome: evaluation by computed tomography perfusion imaging[J]. Eur Radiol, 2021, 31(11): 8364-8373. DOI: 10.1007/s00330-021-07960-4.
[62]
TORTORA D, SEVERINOe M, PACETTI M, et al. Noninvasive Assessment of Hemodynamic Stress Distribution after Indirect Revascularization for Pediatric Moyamoya Vasculopathy[J]. AJNR Am J Neuroradiol, 2018, 39(6): 1157-1163. DOI: 10.3174/ajnr.A5627.
[63]
WANG X, LIU Z, ZHOU Z, et al. Cognitive dysfunction in Moyamoya disease: latest developments and future directions[J/OL]. Front Hum Neurosci, 2024, 18: 1502318 [2025-01-25]. https://doi.org/10.3389/fnhum.2024.1502318. DOI: 10.3389/fnhum.2024.1502318.
[64]
XU Y H, ZHAO J B, ZHANG G X, et al. Research progress on brain white matter injury and cognitive decline in Moyamoya disease patients[J]. Journal of Clinical Neurosurgery, 2024, 21(4): 452-455, 459. DOI: 10.3969/j.issn.1672-7770.2024.04.018.
[65]
HU J, LI Y, LI Z, et al. Abnormal brain functional and structural connectivity between the left supplementary motor area and inferior frontal gyrus in Moyamoya disease[J/OL]. BMC Neurol, 2022, 22(1): 179 [2025-01-25]. https://doi.org/10.1186/s12883-022-02705-2. DOI: 10.1186/s12883-022-02705-2.
[66]
ZHU H, WANG P, LI W, et al. Reorganization of gray matter networks in patients with Moyamoya disease[J/OL]. Sci Rep, 2025, 15(1): 2788 [2025-01-25]. https://doi.org/10.1038/s41598-025-86553-3. DOI: 10.1038/s41598-025-86553-3.
[67]
HE S, LIU Z, WWI Y, et al. Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease[J/OL]. BMC Neurosci, 2021, 22(1): 35 [2025-01-25]. https://doi.org/10.1186/s12868-021-00638-z. DOI: 10.1186/s12868-021-00638-z.
[68]
LU M, ZHENG Y, LIU S, et al. Deep learning model for automated diagnosis of Moyamoya disease based on magnetic resonance angiography[J/OL]. EClinicalMedicine, 2024, 77: 102888 [2025-01-25]. https://doi.org/10.1016/j.eclinm.2024.102888. DOI: 10.1016/j.eclinm.2024.102888.
[69]
SANTANA L S, LEITE M, YOSHIKAWA M H, et al. Evaluation of deep learning algorithms in detecting Moyamoya disease: a systematic review and single-arm meta-analysis[J/OL]. Neurosurg Rev, 2024, 47(1): 300 [2025-01-25]. https://doi.org/10.1007/s10143-024-02537-3. DOI: 10.1007/s10143-024-02537-3.
[70]
FUSE Y, ISHII K, KANAMORI F, et al. Development and validation of machine learning models to predict postoperative infarction in Moyamoya disease[J]. Neurosurg, 2024, 141(4): 927-935. DOI: 10.3171/2024.1.JNS232173.
[71]
SU R R, OUYANG Y, TANG X M, et al. A study on cerebral hemodynamics in Moyamoya disease after combined revascularization surgery based on time to maximum of the residue function[J]. Radiologic Practice, 2025, 40(3): 302-307. DOI: 10.13609/j.cnki.1000-0313.2025.03.003.
[72]
LING H, HUANG H, FU B, et al. Clinical Characteristics and Multi-Model Imaging Analysis of Moyamoya Disease: An Observational Study[J/OL]. Craniofac Surg, 2025, 36(1): e45-e49 [2025-01-25]. https://doi.org/10.1097/SCS.0000000000010765. DOI: 10.1097/SCS.0000000000010765.

PREV Deep learning-based multimodal magnetic resonance imaging techniques and their research progress in depression diagnosis and treatment
NEXT The recent research development of susceptibility vessel sign in acute ischemic stroke
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn